Posts Tagged: Stem cell

News

Coronavirus: $5.5 billion stem cell bond at risk?

Signature gathering in Ventura County during the 2018 election cycle. (Photo: Michael Gordon, via Shutterstock)

The current coronavirus emergency and the practice of social distancing are likely to put a crimp in gathering signatures to qualify a $5.5 billion stem cell initiative for the November ballot in California.

News

Stem cell agency indirectly boosted by national industry group

A clinical researcher with a multi-pipette arrangement of cancer stem cells. (Photo: Science Photo, via Shutterstock)

One of the nation’s leading regenerative medicine industry groups is touting multi-billion dollar savings that may be achieved with the type of stem cell and gene therapies that are being developed with cash from California’s financially beleaguered stem cell program.

News

Stem cell agency officially files $5.5 billion ballot measure

Stem cells for treating cancer in microtubes. (Image: Science Photo, via Shutterstock)

Backers of the financially stressed California stem cell agency yesterday filed their proposed ballot measure to refinance the agency with $5.5 billion if voters approve it in November 2020. The complex, 30-page initiative  would also restructure a number of aspects of the agency and provide for financial assistance for patients and their families who might be involved in clinical trials.

News

USC pays UCSD $50 million to settle recruitment fight

Students outside the library at the University of California, San Diego. (Photo: Stanislavsky, via Shutterstock)

The University of Southern California in Los Angeles is coughing up $50 million and publicly apologizing for its tactics in recruiting a star Alzheimer’s researcher from UC San Diego, it was reported Thursday. The Los Angeles Times story about the unprecedented settlement described the case as an “ugly academic war.” It had the potential of bringing $340 million in research grants to USC.  

News

$5.5 billion stem cell bond called a ‘moral obligation’

A scientist examines cells in a biological laboratory. (Photo: anyalvanova, via Shutterstock)

The man expected to lead the drive for $5.5 billion more for California’s stem cell agency today said the Trump restrictions on fetal tissue research represent a dangerous precedent that threatens the health of all Americans. 

News

Changes eyed as stem cell agency seeks $5 billion

Robert Klein at a November 2017 meeting of CIRM directors. (Photo: California Stem Cell Report)

The man regarded as the father of the $3 billion California stem cell agency is thinking about changes in the program to help win voter approval of another $5 billion for the research program. They include a stronger requirement to make state-backed, stem cell therapies more affordable and accessible and to provide more cash for creating a greater stem cell work force in the Golden State.

News

State stem cell agency looks to avoid extinction

A stem cell researcher examines a vial in the laboratory. (Image: CI Photos, via Shutterstock)

In just nine days, the California stem cell agency will take a close look at its future, examining its budget for the coming fiscal year as well as the possibilities for a ballot initiative in 2020 that could stave off its financial demise. The $3 billion enterprise, known formally as the California Institute for Regenerative Medicine (CIRM), expects to run out cash for new research awards this year, perhaps as early as September.

News

State going slow targeting ‘snake oil’ stem cell clinics

Stem cell research involving a "PCR" strip. (Photo: Science Photo, via Shutterstock)

California Attorney General Xavier Becerra is remaining mum on regulation of “snake oil,” stem cell clinics as the Golden State pursues a go-slow approach to cracking down on the dubious treatments.More than 100 such clinics are operating in California, the most of any state in the nation. New York state earlier this month took the lead among states in attempting to regulate the clinics.

News

An effort to regulate California stem cell clinics

Stem cell research in what is known as a "PCR strip." (Image: Science Photo, via Shutterstock)

Legislation to help stem the tide of unregulated stem cell clinics in California is still being drafted, but is expected to be introduced by the end of this month. Art Torres, vice chairman of the California stem cell agency, is working on the measure, which is expected to be authored by Assemblyman Kevin Mullin, D-San Mateo. 

News

California’s gene therapy effort is nation’s first

The science of gene therapy and health care, a concept illustration. (Image: Kentoh, via Shutterstock)

California today became the first state in the nation to launch itself into the sizzling field of gene therapy, backed by tens of millions of dollars and with the hope of creating treatments that could permanently cure afflictions ranging from hemophilia to cancer.

Support for Capitol Weekly is Provided by: